AGIOS PHARMACEUTICALS, INC. (AGIO) › RevenueAGIOS PHARMACEUTICALS, INC. (AGIO) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $69.89M2017: $43.01M2018: $94.39M2019: $117.91M2020: $02021: $02022: $14.24M2023: $26.82M2024: $36.50M2025: $54.03M$54.03M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$54.03M+48.0%2024$36.50M+36.1%2023$26.82M+88.4%2022$14.24M—2021$0—2020$0-100.0%2019$117.91M+24.9%2018$94.39M+119.4%2017$43.01M-38.5%2016$69.89M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share